Literature DB >> 17558677

Substance P up-regulates matrix metalloproteinase-1 and down-regulates collagen in human lung fibroblast.

Carlos Ramos1, Martha Montaño, Jose Cisneros, Bettina Sommer, Javier Delgado, Georgina Gonzalez-Avila.   

Abstract

Substance P is involved in inflammatory processes, but its effect on extracellular matrix metabolism has not been studied; therefore, the authors evaluated its effect on collagen synthesis and degradation, expression of pro-alpha1(I) collagen, matrix metalloproteinase-1 and -2, and tissue inhibitor of metalloproteinase-1 and -2 in normal human lung fibroblast strains. Substance P induced a decrease in collagen biosynthesis, concomitant to a down-regulation of pro-alpha1(I) collagen mRNA. In contrast, an increase in collagen degradation was observed, accompanied with an up-regulation of matrix metalloproteinase-1. Substance P did not influence tissue inhibitor of metalloproteinase-1 and -2 or matrix metalloproteinase-2 expression. The results suggest that substance P participates in extracellular matrix metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558677     DOI: 10.1080/01902140701364409

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  8 in total

1.  Anchoring a cytoactive factor in a wound bed promotes healing.

Authors:  Sayani Chattopadhyay; Kathleen M Guthrie; Leandro Teixeira; Christopher J Murphy; Richard R Dubielzig; Jonathan F McAnulty; Ronald T Raines
Journal:  J Tissue Eng Regen Med       Date:  2014-03-27       Impact factor: 3.963

2.  Biological characteristics of tracheal smooth muscle cells regulated by NK-1R in asthmatic rat with airway remodeling.

Authors:  Bing Wei; Yali Liu; Xiaozhe Yue; Yinping Li; Yunxiao Shang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Substance P modulates colitis-associated fibrosis.

Authors:  Hon Wai Koon; David Shih; Iordanes Karagiannides; Dezheng Zhao; Zafeer Fazelbhoy; Tressia Hing; Hua Xu; Bao Lu; Norma Gerard; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

4.  Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

Authors:  Giselle C Meléndez; Jianping Li; Brittany A Law; Joseph S Janicki; Scott C Supowit; Scott P Levick
Journal:  Cardiovasc Res       Date:  2011-09-09       Impact factor: 10.787

5.  Substance P increases CCN2 dependent on TGF-beta yet Collagen Type I via TGF-beta1 dependent and independent pathways in tenocytes.

Authors:  Nagat Frara; Paul W Fisher; Yingjie Zhao; Joseph T Tarr; Mamta Amin; Steven N Popoff; Mary F Barbe
Journal:  Connect Tissue Res       Date:  2017-04-12       Impact factor: 3.417

Review 6.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

7.  An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally.

Authors:  Rizal Lim; Jonathan M Morrill; Scott G Prushik; Karen L Reed; Adam C Gower; Susan E Leeman; Arthur F Stucchi; James M Becker
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

8.  Substance P and patterned silk biomaterial stimulate periodontal ligament stem cells to form corneal stroma in a bioengineered three-dimensional model.

Authors:  Jialin Chen; Wei Zhang; Peyman Kelk; Ludvig J Backman; Patrik Danielson
Journal:  Stem Cell Res Ther       Date:  2017-11-13       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.